PT3081097T - Composição para o tratamento da infertilidade - Google Patents

Composição para o tratamento da infertilidade

Info

Publication number
PT3081097T
PT3081097T PT161711478T PT16171147T PT3081097T PT 3081097 T PT3081097 T PT 3081097T PT 161711478 T PT161711478 T PT 161711478T PT 16171147 T PT16171147 T PT 16171147T PT 3081097 T PT3081097 T PT 3081097T
Authority
PT
Portugal
Prior art keywords
infertility
treatment
composition
Prior art date
Application number
PT161711478T
Other languages
English (en)
Original Assignee
Uriach Italy S R L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=43736968&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT3081097(T) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Uriach Italy S R L filed Critical Uriach Italy S R L
Publication of PT3081097T publication Critical patent/PT3081097T/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12Fatty acids or derivatives thereof
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15Vitamins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/38Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/385Heterocyclic compounds having sulfur as a ring hetero atom having two or more sulfur atoms in the same ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/661Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
    • A61K31/6615Compounds having two or more esterified phosphorus acid groups, e.g. inositol triphosphate, phytic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/24Drugs for disorders of the endocrine system of the sex hormones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs
PT161711478T 2010-12-17 2011-12-19 Composição para o tratamento da infertilidade PT3081097T (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI2010A002313A IT1403587B1 (it) 2010-12-17 2010-12-17 Composizione per il trattamento di disordini metabolici

Publications (1)

Publication Number Publication Date
PT3081097T true PT3081097T (pt) 2020-01-14

Family

ID=43736968

Family Applications (2)

Application Number Title Priority Date Filing Date
PT118133586T PT2651251T (pt) 2010-12-17 2011-12-19 Composição para o tratamento de distúrbios metabólicos
PT161711478T PT3081097T (pt) 2010-12-17 2011-12-19 Composição para o tratamento da infertilidade

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PT118133586T PT2651251T (pt) 2010-12-17 2011-12-19 Composição para o tratamento de distúrbios metabólicos

Country Status (12)

Country Link
EP (2) EP3081097B8 (pt)
BR (1) BR112013015048A2 (pt)
DK (2) DK2651251T3 (pt)
ES (2) ES2586930T3 (pt)
HR (1) HRP20160978T1 (pt)
HU (2) HUE047320T2 (pt)
IT (1) IT1403587B1 (pt)
PL (2) PL2651251T3 (pt)
PT (2) PT2651251T (pt)
RS (1) RS55057B1 (pt)
RU (1) RU2586742C2 (pt)
WO (1) WO2012080831A1 (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112012017554B8 (pt) 2010-01-14 2021-05-25 Crescita Therapeutics Inc formulações de anestésicas locais formadoras de sólido para controle da dor
ITMI20130349A1 (it) * 2013-03-07 2014-09-08 Laborest Italia S P A Composizione per uso nel trattamento della sindrome dell ovaio policistico
ITUA20163025A1 (it) 2016-04-29 2017-10-29 Sochim Int S P A Composizione per il trattamento della sindrome dell’ovaio policistico
US11898184B2 (en) 2017-09-07 2024-02-13 Sweet Sense Inc. Low glycemic sugar composition
RU2757220C1 (ru) * 2020-06-03 2021-10-12 Общество с ограниченной ответственностью "ОКТАВА ХОЛДИНГ" Фармацевтическая композиция для профилактики и лечения синдрома поликистозных яичников

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2152787C2 (ru) * 1994-06-02 2000-07-20 Дан Рига Лекарство против стресса, против снижения уровня активности и против старения и способ его получения
US20020155163A1 (en) * 1999-12-27 2002-10-24 Samuel D. Benjamin Integrated multi-vitamin and mineral combination
US20040043013A1 (en) * 2000-12-28 2004-03-04 Mccleary Edward Larry Metabolic uncoupling therapy
US20070065456A1 (en) * 2005-09-20 2007-03-22 Woods Cindy J Nutritional supplements

Also Published As

Publication number Publication date
PT2651251T (pt) 2016-08-19
RU2586742C2 (ru) 2016-06-10
IT1403587B1 (it) 2013-10-31
BR112013015048A2 (pt) 2016-07-19
RU2013130308A (ru) 2015-01-27
EP2651251A1 (en) 2013-10-23
ES2586930T3 (es) 2016-10-19
PL2651251T3 (pl) 2017-06-30
HUE029493T2 (en) 2017-02-28
ITMI20102313A1 (it) 2012-06-18
RS55057B1 (sr) 2016-12-30
ES2763437T3 (es) 2020-05-28
DK3081097T3 (da) 2020-01-20
DK2651251T3 (en) 2016-09-05
WO2012080831A1 (en) 2012-06-21
EP3081097A1 (en) 2016-10-19
HUE047320T2 (hu) 2020-04-28
PL3081097T3 (pl) 2020-06-15
HRP20160978T1 (hr) 2016-10-07
EP3081097B1 (en) 2019-12-04
EP2651251B1 (en) 2016-06-01
EP3081097B8 (en) 2020-01-08

Similar Documents

Publication Publication Date Title
EP2554175A4 (en) COMPOSITION FOR THE TREATMENT OF A DESIRED PART
HK1218724A1 (zh) 用於治療瘻的組合物
PT2523661T (pt) Inibidores de nkcc para o tratamento de autismo
EP2552874A4 (en) PROCESS FOR PREPARING HEXAFLUOR-2 BUTENE
EP2654745A4 (en) COMPOSITION FOR TREATING SKIN CONDITIONS OF THE SKIN
RS63996B1 (sr) Kompozicije za lečenje mijelofibroze
EP2558432A4 (en) METHOD FOR THE PRODUCTION OF TETRAFLUOROLEFINES
SG2014014724A (en) METHODS FOR THE TREATMENT OF IL-1ß RELATED CONDITIONS
SI2605764T1 (sl) Sestavki za zdravljenje raka
PL2651251T3 (pl) Kompozycja do leczenia bezpłodności
EP2536436A4 (en) ANTIMIR-451 FOR THE TREATMENT OF POLYCYTHEMICS
EP2596007A4 (en) PROCESS FOR THE PREPARATION OF 17-DEOXY-CORTICOSTEROIDS
EP2560679A4 (en) TREATMENT OF ECZEMA
ZA201300546B (en) Process for the preparation of 3-haloalkylpyrazoles
PL2460509T3 (pl) Kompozycja do leczenia brodawek
IL222072A (en) Composition for the treatment of primary thrombocythemia
PL2593423T3 (pl) Proces wytwarzania środków kontrastowych
PT2390246T (pt) Processo para a preparação de aminaftona
PT2598504E (pt) Novo processo de fabrico de dimiracetam
IL223055A0 (en) Compositions for the treatment of gynaecological disorders
GB201007519D0 (en) Means for inhibiting the expression of rragb
GB201016836D0 (en) Composition for skin treatment
GB201016834D0 (en) Composition for skin treatment
GB201012310D0 (en) Composition for the treatment of botulism
IL224304A (en) A process for making dichlorobulben